Company news

Neuronetics, Inc. news in 2025

Neuronetics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference

November 20, 2025

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

November 12, 2025

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

November 4, 2025

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

October 31, 2025

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

October 30, 2025

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

October 21, 2025

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

September 17, 2025

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

August 5, 2025

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

August 4, 2025

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

July 30, 2025

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

July 22, 2025

Neuronetics Appoints New Chief Financial Officer

July 15, 2025

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

June 10, 2025

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

June 2, 2025

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

May 14, 2025

Neuronetics Reports First Quarter 2025 Financial and Operating Results

May 6, 2025

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

April 22, 2025

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

March 31, 2025

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

March 27, 2025

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

March 4, 2025

Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call

February 21, 2025

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock

February 6, 2025

Neuronetics Announces Launch of Underwritten Public Offering of Common Stock

February 5, 2025

NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression

January 28, 2025

Neuronetics Provides Business Update and Issues 2025 Guidance

January 12, 2025

Calls in 2025

Decks in 2025